SpyGlass Pharma SGP
NASDAQ SGP
$26.02 +0.58 (+2.30%)
As of: Sep 30, 2026 · 10:23 AM EDT

SpyGlass Pharma (SGP) Market Capitalization (2026)

Updated

SpyGlass Pharma (SGP) posted Market Capitalization of $744.51 million for Q2 2026.

Analysis

SpyGlass Pharma (SGP) Market Capitalization (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 SpyGlass Pharma 868.94 Mn 868.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 744.51 Mn
API Access

SpyGlass Pharma Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=SGP&period=max&api_key=YOUR_API_KEY